Cargando…
Intrahepatic Cholangiocarcinoma: A Summative Review of Biomarkers and Targeted Therapies
SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma is the second most common primary liver malignancy. Among patients with operable disease, surgical resection is the cornerstone of therapy. Among the majority of patients who present with advanced disease treatment, systemic or targeted therapy is indi...
Autores principales: | Acher, Alexandra W., Paro, Alessandro, Elfadaly, Ahmed, Tsilimigras, Diamantis, Pawlik, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533913/ https://www.ncbi.nlm.nih.gov/pubmed/34680318 http://dx.doi.org/10.3390/cancers13205169 |
Ejemplares similares
-
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
por: Serifis, Nikolaos, et al.
Publicado: (2021) -
Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma
por: Akateh, Clifford, et al.
Publicado: (2020) -
Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles
por: Beal, Eliza W., et al.
Publicado: (2020) -
Staging and Prognostic Models for Hepatocellular Carcinoma and
Intrahepatic Cholangiocarcinoma
por: Burkhart, Richard A., et al.
Publicado: (2017) -
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Machairas, Nikolaos, et al.
Publicado: (2022)